Human intestinal microbial metabolism of naringin

Naringin, a major flavonoid in citrus fruits, has been proved to be a promising antitussive candidate. It undertakes complicated metabolism. In this study, human intestinal microbial metabolism of naringin was studied in vitro. Six persons’ fecal water, which have intestinal microbial enzyme, were u...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of drug metabolism and pharmacokinetics Vol. 40; no. 3; pp. 363 - 367
Main Authors Zou, Wei, Luo, Yulong, Liu, Menghua, Chen, Si, Wang, Sheng, Nie, Yichu, Cheng, Guohua, Su, Weiwei, Zhang, Kejian
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.09.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Naringin, a major flavonoid in citrus fruits, has been proved to be a promising antitussive candidate. It undertakes complicated metabolism. In this study, human intestinal microbial metabolism of naringin was studied in vitro. Six persons’ fecal water, which have intestinal microbial enzyme, were used in the first experiment. Naringin was metabolized by fecal water into naringenin. Subsequently, 3-(4-hydroxyphenyl)propionic acid (4-HPPA) was produced with naringenin degradation by a person’s fecal water. However, 4-HPPA was not detected after naringenin degradation by the other 5 subjects’ fecal water and the reason might be that the degrading velocity of 4-HPPA exceeded the producing velocity. To confirm the difference in degrading 4-HPPA among human feces, 22 healthy persons’ feces were used for incubation. In this second experiment, 15 persons’ feces could degrade 4-HPPA, but the other 7 subjects’ could not. Human feces showed different ability of degrading 4-HPPA, and there are no gender differences. These results may be helpful for explaining findings in pharmacological and toxicological studies and are groundwork for clinical studies.
AbstractList Naringin, a major flavonoid in citrus fruits, has been proved to be a promising antitussive candidate. It undertakes complicated metabolism. In this study, human intestinal microbial metabolism of naringin was studied in vitro. Six persons' fecal water, which have intestinal microbial enzyme, were used in the first experiment. Naringin was metabolized by fecal water into naringenin. Subsequently, 3-(4-hydroxyphenyl)propionic acid (4-HPPA) was produced with naringenin degradation by a person's fecal water. However, 4-HPPA was not detected after naringenin degradation by the other 5 subjects' fecal water and the reason might be that the degrading velocity of 4-HPPA exceeded the producing velocity. To confirm the difference in degrading 4-HPPA among human feces, 22 healthy persons' feces were used for incubation. In this second experiment, 15 persons' feces could degrade 4-HPPA, but the other 7 subjects' could not. Human feces showed different ability of degrading 4-HPPA, and there are no gender differences. These results may be helpful for explaining findings in pharmacological and toxicological studies and are groundwork for clinical studies.
Naringin, a major flavonoid in citrus fruits, has been proved to be a promising antitussive candidate. It undertakes complicated metabolism. In this study, human intestinal microbial metabolism of naringin was studied in vitro. Six persons' fecal water, which have intestinal microbial enzyme, were used in the first experiment. Naringin was metabolized by fecal water into naringenin. Subsequently, 3-(4-hydroxyphenyl)propionic acid (4-HPPA) was produced with naringenin degradation by a person's fecal water. However, 4-HPPA was not detected after naringenin degradation by the other 5 subjects' fecal water and the reason might be that the degrading velocity of 4-HPPA exceeded the producing velocity. To confirm the difference in degrading 4-HPPA among human feces, 22 healthy persons' feces were used for incubation. In this second experiment, 15 persons' feces could degrade 4-HPPA, but the other 7 subjects' could not. Human feces showed different ability of degrading 4-HPPA, and there are no gender differences. These results may be helpful for explaining findings in pharmacological and toxicological studies and are groundwork for clinical studies.Naringin, a major flavonoid in citrus fruits, has been proved to be a promising antitussive candidate. It undertakes complicated metabolism. In this study, human intestinal microbial metabolism of naringin was studied in vitro. Six persons' fecal water, which have intestinal microbial enzyme, were used in the first experiment. Naringin was metabolized by fecal water into naringenin. Subsequently, 3-(4-hydroxyphenyl)propionic acid (4-HPPA) was produced with naringenin degradation by a person's fecal water. However, 4-HPPA was not detected after naringenin degradation by the other 5 subjects' fecal water and the reason might be that the degrading velocity of 4-HPPA exceeded the producing velocity. To confirm the difference in degrading 4-HPPA among human feces, 22 healthy persons' feces were used for incubation. In this second experiment, 15 persons' feces could degrade 4-HPPA, but the other 7 subjects' could not. Human feces showed different ability of degrading 4-HPPA, and there are no gender differences. These results may be helpful for explaining findings in pharmacological and toxicological studies and are groundwork for clinical studies.
Author Su, Weiwei
Zhang, Kejian
Zou, Wei
Chen, Si
Liu, Menghua
Luo, Yulong
Wang, Sheng
Nie, Yichu
Cheng, Guohua
Author_xml – sequence: 1
  givenname: Wei
  surname: Zou
  fullname: Zou, Wei
  organization: Guangzhou Quality R&D Center of Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Science, Sun Yat-sen University
– sequence: 2
  givenname: Yulong
  surname: Luo
  fullname: Luo, Yulong
  organization: Guangzhou Quality R&D Center of Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Science, Sun Yat-sen University
– sequence: 3
  givenname: Menghua
  surname: Liu
  fullname: Liu, Menghua
  organization: Guangzhou Quality R&D Center of Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Science, Sun Yat-sen University
– sequence: 4
  givenname: Si
  surname: Chen
  fullname: Chen, Si
  organization: Guangzhou Quality R&D Center of Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Science, Sun Yat-sen University
– sequence: 5
  givenname: Sheng
  surname: Wang
  fullname: Wang, Sheng
  organization: Guangzhou Quality R&D Center of Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Science, Sun Yat-sen University
– sequence: 6
  givenname: Yichu
  surname: Nie
  fullname: Nie, Yichu
  organization: Guangzhou Quality R&D Center of Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Science, Sun Yat-sen University
– sequence: 7
  givenname: Guohua
  surname: Cheng
  fullname: Cheng, Guohua
  organization: Pharmacy College, Jinan University
– sequence: 8
  givenname: Weiwei
  surname: Su
  fullname: Su, Weiwei
  email: lssswwhk@gmail.com
  organization: Guangzhou Quality R&D Center of Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Science, Sun Yat-sen University
– sequence: 9
  givenname: Kejian
  surname: Zhang
  fullname: Zhang, Kejian
  email: zkj5566@sohu.com
  organization: School of Pharmaceutical Sciences, Sun Yat-Sen University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24935725$$D View this record in MEDLINE/PubMed
BookMark eNp9kMtKAzEUhoNUbK19ADfSpZvRXCa3pRRvUHCj65DJJJIyk6nJDNS3N8NUFy56IJwEvv-Q812CWeiCBeAawTsEIb9PiBAkCojKfCQpDmdggRHk-SXgDCwg4aLgkrE5WKW0g7mIkJSyCzDHpSSUY7oA6GVodVj70NvU-6CbdetN7Co_3myvq67xqV13bh109OHThytw7nST7OrYl-Dj6fF981Js355fNw_bwpQC9oWVJaUOIyeZsbWTQjCBHWGcGiZhpStIHZWGM4O04DXWmtWYUa0ry5zBNVmC22nuPnZfQ_6dan0ytml0sN2QFOJQCEkEJxm9OaJD1dpa7aNvdfxWv2tmAE1AXi2laN0fgqAabarJpso21WhTHXKG_8sY3-ved6GP2jcnk3hKpv2ozEa164aY3aYToR-iZ4h8
CitedBy_id crossref_primary_10_1016_j_jpba_2018_08_039
crossref_primary_10_1007_s13318_016_0380_z
crossref_primary_10_3390_molecules24234287
crossref_primary_10_1016_j_jafr_2023_100583
crossref_primary_10_1016_j_jnutbio_2019_108255
crossref_primary_10_2174_1389557519666191009162641
crossref_primary_10_1080_10520295_2017_1305499
crossref_primary_10_1039_C6FO01851C
crossref_primary_10_3390_molecules23040895
crossref_primary_10_1016_j_jchromb_2019_121846
crossref_primary_10_1002_ptr_6641
crossref_primary_10_3390_antiox9100982
crossref_primary_10_1016_j_phrs_2020_105264
crossref_primary_10_1016_j_biopha_2019_109439
crossref_primary_10_1016_j_jchromb_2017_07_015
crossref_primary_10_3390_nu14183765
crossref_primary_10_1016_j_biopha_2018_09_092
crossref_primary_10_1080_10408398_2020_1746234
crossref_primary_10_3390_metabo15030146
crossref_primary_10_2903_j_efsa_2024_8747
crossref_primary_10_1016_j_scitotenv_2024_177073
crossref_primary_10_1021_acs_jafc_7b01486
crossref_primary_10_3390_molecules24040679
crossref_primary_10_1016_j_apt_2022_103627
crossref_primary_10_1002_fft2_25
crossref_primary_10_1016_S1875_5364_18_30088_8
crossref_primary_10_1007_s00210_024_03672_w
crossref_primary_10_1016_j_fct_2017_11_057
crossref_primary_10_3389_fphar_2019_00034
crossref_primary_10_1007_s11596_024_2921_z
crossref_primary_10_1021_acs_jafc_9b06494
Cites_doi 10.1016/j.ejphar.2012.06.040
10.1007/s00203-004-0676-2
10.1042/bj1301161
10.1007/BF03216747
10.1002/bdd.1775
10.1128/AEM.71.10.6077-6085.2005
10.1007/BF02973933
10.1016/j.anaerobe.2005.11.002
10.1016/j.intimp.2011.05.022
10.1128/MMBR.65.4.523-569.2001
10.1089/jmf.2012.2251
10.1055/s-0030-1250117
10.1007/s002030050010
10.1006/bbrc.2001.5001
10.1055/s-0031-1299746
10.1124/dmd.32.4.387
10.1007/s00394-003-0397-3
10.1016/j.intimp.2012.04.019
10.1016/j.freeradbiomed.2003.09.022
10.1021/jf0108056
10.1159/000139228
10.1007/s11101-008-9095-3
10.1016/0891-5849(90)90045-K
10.1016/j.etap.2011.01.006
10.1248/cpb.49.1640
10.1093/jn/135.1.48
10.1093/jn/136.6.1477
10.1093/jn/131.10.2648
ContentType Journal Article
Copyright Springer International Publishing Switzerland 2014
Copyright_xml – notice: Springer International Publishing Switzerland 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1007/s13318-014-0193-x
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 2107-0180
EndPage 367
ExternalDocumentID 24935725
10_1007_s13318_014_0193_x
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-EM
.GJ
06D
0R~
0VY
1N0
2.D
2JN
2KG
2VQ
30V
4.4
406
408
40D
53G
5GY
67N
96X
AAAUJ
AABHQ
AACDK
AAEWM
AAIAL
AAIKX
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AAWCG
AAYIU
AAYOK
AAYQN
AAYTO
AAYZH
AAZMS
ABAKF
ABDZT
ABFTV
ABHLI
ABJNI
ABJOX
ABKCH
ABKMS
ABPLI
ABQBU
ABTKH
ABTMW
ABWHX
ABXPI
ACAOD
ACBXY
ACCOQ
ACDTI
ACGFS
ACKNC
ACMLO
ACPIV
ACZOJ
ADFZG
ADHHG
ADHIR
ADINQ
ADKPE
ADRFC
ADURQ
ADYPR
ADZKW
AEBTG
AEFQL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETCA
AEVLU
AEXYK
AEYRQ
AFBBN
AFLOW
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGQEE
AGQMX
AGRTI
AGWZB
AGYKE
AHAVH
AHBYD
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AJBLW
AJRNO
ALFXC
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMXSW
AMYLF
AMYQR
ANMIH
ASPBG
AVWKF
AWSVR
AXYYD
AZFZN
BBWZM
BGNMA
CSCUP
DNIVK
DPUIP
DU5
EBLON
EBS
EIOEI
EJD
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FLLZZ
FNLPD
FRRFC
FSGXE
GGRSB
GJIRD
GNWQR
GQ6
GQ7
H13
HF~
HMJXF
HRMNR
HVGLF
HZ~
ITM
IWAJR
J-C
JBSCW
JZLTJ
KOV
LLZTM
M4Y
NQJWS
NU0
O9-
P2P
R9I
RLLFE
ROL
RSV
S1Z
S27
S3A
S3B
SBL
SBY
SCLPG
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPKJE
SRMVM
SSLCW
T13
TSG
U2A
U9L
UG4
UTJUX
UZXMN
VC2
VDBLX
VFIZW
W48
WK8
Z45
Z7U
Z87
~A9
~JE
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c480t-e9455f21f96cedf988682f3675c690bab05f59c76c1a87d2aa6d265aabe6fc2d3
IEDL.DBID U2A
ISSN 0378-7966
2107-0180
IngestDate Fri Jul 11 04:46:28 EDT 2025
Thu Apr 03 07:02:03 EDT 2025
Thu Apr 24 22:57:18 EDT 2025
Tue Jul 01 04:04:08 EDT 2025
Fri Feb 21 02:35:50 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords 3-(4-Hydroxyphenyl)propionic acid
Naringin
Metabolism
Human intestinal microbiota
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c480t-e9455f21f96cedf988682f3675c690bab05f59c76c1a87d2aa6d265aabe6fc2d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 24935725
PQID 1708893873
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_1708893873
pubmed_primary_24935725
crossref_primary_10_1007_s13318_014_0193_x
crossref_citationtrail_10_1007_s13318_014_0193_x
springer_journals_10_1007_s13318_014_0193_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-09-01
PublicationDateYYYYMMDD 2015-09-01
PublicationDate_xml – month: 09
  year: 2015
  text: 2015-09-01
  day: 01
PublicationDecade 2010
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: France
PublicationTitle European journal of drug metabolism and pharmacokinetics
PublicationTitleAbbrev Eur J Drug Metab Pharmacokinet
PublicationTitleAlternate Eur J Drug Metab Pharmacokinet
PublicationYear 2015
Publisher Springer International Publishing
Publisher_xml – name: Springer International Publishing
References Aura (CR1) 2008; 7
Herles, Braune, Blaut (CR10) 2004; 181
Kim, Jung, Sohng, Han, Kim, Han (CR11) 1998; 21
Lee, Jeong, Choi, Hyun, Oh, Kim, Kim, Han, Bok (CR12) 2001; 284
Liu, Wu, Nie, Chen, Su, Li (CR14) 2011; 11
Walle, Walle, Halushka (CR25) 2001; 131
Griffiths, Barrow (CR8) 1972; 130
Zou, Yang, Liu, Su (CR29) 2012; 62
Diaz, Ferrandez, Prieto, Garcia (CR6) 2001; 65
Clavel, Henderson, Alpert, Philippe, Rigottier-Gois, Dore, Blaut (CR4) 2005; 71
Nikolic, van Breemen (CR21) 2004; 32
Chen, Zheng, Jia, Ju (CR3) 1990; 9
Liu, Zou, Yang, Peng, Su (CR15) 2012; 33
Liu, Yang, Zou, Guan, Zheng, Lai, Fang, Cai, Su (CR13) 2011; 31
Luo, Zhang, Li, Nie, Wu, Shen, Su (CR16) 2012; 13
Martin, Marhuenda, Perez-Guerrero, Franco (CR17) 1994; 49
Wang, Meselhy, Li, Nakamura, Min, Qin, Hattori (CR27) 2001; 49
Aura, O’Leary, Williamson, Ojala, Bailey, Puupponen-Pimia, Nuutila, Oksman-Caldentey, Poutanen (CR2) 2002; 50
Rechner, Smith, Kuhnle, Gibson, Debnam, Srai, Moore, Rice-Evans (CR22) 2004; 36
CR9
Yu, Jang, Kang, Sung, Kim (CR28) 1997; 20
Walle, Browning, Steed, Reed, Walle (CR26) 2005; 135
Nie, Wu, Li, Luo, Long, Xie, Shen, Su (CR19) 2012; 15
Schneider, Blaut (CR24) 2000; 173
Gao, Li, Yang, Fang, Su (CR7) 2011; 77
Nemeth, Plumb, Berrin, Juge, Jacob, Naim, Williamson, Swallow, Kroon (CR18) 2003; 42
Schindler, Mentlein (CR23) 2006; 136
Nie, Wu, Li, Xie, Luo, Shen, Su (CR20) 2012; 690
Clavel, Borrmann, Braune, Dore, Blaut (CR5) 2006; 12
YL Luo (193_CR16) 2012; 13
K Nemeth (193_CR18) 2003; 42
E Diaz (193_CR6) 2001; 65
DH Kim (193_CR11) 1998; 21
CH Lee (193_CR12) 2001; 284
R Schindler (193_CR23) 2006; 136
YC Nie (193_CR20) 2012; 690
D Nikolic (193_CR21) 2004; 32
C Herles (193_CR10) 2004; 181
T Clavel (193_CR4) 2005; 71
T Walle (193_CR25) 2001; 131
MJ Martin (193_CR17) 1994; 49
M Liu (193_CR15) 2012; 33
LA Griffiths (193_CR8) 1972; 130
H Schneider (193_CR24) 2000; 173
YC Nie (193_CR19) 2012; 15
S Gao (193_CR7) 2011; 77
LQ Wang (193_CR27) 2001; 49
193_CR9
AM Aura (193_CR1) 2008; 7
KU Yu (193_CR28) 1997; 20
T Clavel (193_CR5) 2006; 12
AR Rechner (193_CR22) 2004; 36
YT Chen (193_CR3) 1990; 9
M Liu (193_CR13) 2011; 31
W Zou (193_CR29) 2012; 62
AM Aura (193_CR2) 2002; 50
Y Liu (193_CR14) 2011; 11
T Walle (193_CR26) 2005; 135
16765860 - Anaerobe. 2006 Jun;12(3):140-7
2170243 - Free Radic Biol Med. 1990;9(1):19-21
22766066 - Eur J Pharmacol. 2012 Sep 5;690(1-3):207-13
22374702 - Biopharm Drug Dispos. 2012 Apr;33(3):123-34
22985397 - J Med Food. 2012 Oct;15(10 ):894-900
20645246 - Planta Med. 2011 Jan;77(1):16-21
11767089 - Chem Pharm Bull (Tokyo). 2001 Dec;49(12):1640-3
14744633 - Free Radic Biol Med. 2004 Jan 15;36(2):212-25
21787720 - Environ Toxicol Pharmacol. 2011 May;31(3):485-9
18982483 - Arch Pharm Res. 1997 Oct;20(5):420-4
9875509 - Arch Pharm Res. 1998 Feb;21(1):17-23
16204524 - Appl Environ Microbiol. 2005 Oct;71(10):6077-85
11879065 - J Agric Food Chem. 2002 Mar 13;50(6):1725-30
15127184 - Arch Microbiol. 2004 Jun;181(6):428-34
12594539 - Eur J Nutr. 2003 Jan;42(1):29-42
10648107 - Arch Microbiol. 2000 Jan;173(1):71-5
4656801 - Biochem J. 1972 Dec;130(4):1161-2
11396955 - Biochem Biophys Res Commun. 2001 Jun 15;284(3):681-8
16702307 - J Nutr. 2006 Jun;136(6):1477-82
15039291 - Drug Metab Dispos. 2004 Apr;32(4):387-97
22270844 - Arzneimittelforschung. 2012 Apr;62(4):181-6
11584085 - J Nutr. 2001 Oct;131(10):2648-52
22575871 - Int Immunopharmacol. 2012 Jul;13(3):301-7
7972328 - Pharmacology. 1994 Sep;49(3):144-50
21640201 - Int Immunopharmacol. 2011 Oct;11(10):1606-12
11729263 - Microbiol Mol Biol Rev. 2001 Dec;65(4):523-69, table of contents
15623831 - J Nutr. 2005 Jan;135(1):48-52
References_xml – volume: 690
  start-page: 207
  issue: 1–3
  year: 2012
  end-page: 213
  ident: CR20
  article-title: Naringin attenuates EGF-induced MUC5AC secretion in A549 cells by suppressing the cooperative activities of MAPKs-AP-1 and IKKs-IkappaB-NF-kappaB signaling pathways
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2012.06.040
– volume: 181
  start-page: 428
  issue: 6
  year: 2004
  end-page: 434
  ident: CR10
  article-title: First bacterial chalcone isomerase isolated from ramulus
  publication-title: Arch Microbiol
  doi: 10.1007/s00203-004-0676-2
– volume: 130
  start-page: 1161
  issue: 4
  year: 1972
  end-page: 1162
  ident: CR8
  article-title: Metabolism of flavonoid compounds in germ-free rats
  publication-title: Biochem J
  doi: 10.1042/bj1301161
– volume: 135
  start-page: 48
  issue: 1
  year: 2005
  end-page: 52
  ident: CR26
  article-title: Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans
  publication-title: J Nutr
– volume: 21
  start-page: 17
  issue: 1
  year: 1998
  end-page: 23
  ident: CR11
  article-title: Intestinal bacterial metabolism of flavonoids and its relation to some biological activities
  publication-title: Arch Pharm Res
  doi: 10.1007/BF03216747
– volume: 136
  start-page: 1477
  issue: 6
  year: 2006
  end-page: 1482
  ident: CR23
  article-title: Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells
  publication-title: J Nutr
– volume: 33
  start-page: 123
  issue: 3
  year: 2012
  end-page: 134
  ident: CR15
  article-title: Metabolism and excretion studies of oral administered naringin, a putative antitussive, in rats and dogs
  publication-title: Biopharm Drug Dispos
  doi: 10.1002/bdd.1775
– volume: 71
  start-page: 6077
  issue: 10
  year: 2005
  end-page: 6085
  ident: CR4
  article-title: Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.71.10.6077-6085.2005
– volume: 20
  start-page: 420
  issue: 5
  year: 1997
  end-page: 424
  ident: CR28
  article-title: Metabolism of saikosaponin c and naringin by human intestinal bacteria
  publication-title: Arch Pharm Res
  doi: 10.1007/BF02973933
– volume: 12
  start-page: 140
  issue: 3
  year: 2006
  end-page: 147
  ident: CR5
  article-title: Occurrence and activity of human intestinal bacteria involved in the conversion of dietary lignans
  publication-title: Anaerobe
  doi: 10.1016/j.anaerobe.2005.11.002
– volume: 11
  start-page: 1606
  issue: 10
  year: 2011
  end-page: 1612
  ident: CR14
  article-title: Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-kappaB pathway
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2011.05.022
– volume: 65
  start-page: 523
  issue: 4
  year: 2001
  end-page: 569
  ident: CR6
  article-title: Biodegradation of aromatic compounds by
  publication-title: Microbiol Mol Biol Rev
  doi: 10.1128/MMBR.65.4.523-569.2001
– volume: 15
  start-page: 894
  issue: 10
  year: 2012
  end-page: 900
  ident: CR19
  article-title: Anti-inflammatory effects of naringin in chronic pulmonary neutrophilic inflammation in cigarette smoke-exposed rats
  publication-title: J Med Food
  doi: 10.1089/jmf.2012.2251
– volume: 77
  start-page: 16
  issue: 1
  year: 2011
  end-page: 21
  ident: CR7
  article-title: Antitussive effect of naringin on experimentally induced cough in
  publication-title: Planta Med
  doi: 10.1055/s-0030-1250117
– volume: 173
  start-page: 71
  issue: 1
  year: 2000
  end-page: 75
  ident: CR24
  article-title: Anaerobic degradation of flavonoids by ramulus
  publication-title: Arch Microbiol
  doi: 10.1007/s002030050010
– volume: 131
  start-page: 2648
  issue: 10
  year: 2001
  end-page: 2652
  ident: CR25
  article-title: Carbon dioxide is the major metabolite of quercetin in humans
  publication-title: J Nutr
– volume: 284
  start-page: 681
  issue: 3
  year: 2001
  end-page: 688
  ident: CR12
  article-title: Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.2001.5001
– volume: 62
  start-page: 181
  issue: 4
  year: 2012
  end-page: 186
  ident: CR29
  article-title: Tissue distribution study of naringin in rats by liquid chromatography-tandem mass spectrometry
  publication-title: Arzneimittelforschung
  doi: 10.1055/s-0031-1299746
– volume: 32
  start-page: 387
  issue: 4
  year: 2004
  end-page: 397
  ident: CR21
  article-title: New metabolic pathways for flavanones catalyzed by rat liver microsomes
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.32.4.387
– volume: 42
  start-page: 29
  issue: 1
  year: 2003
  end-page: 42
  ident: CR18
  article-title: Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans
  publication-title: Eur J Nutr
  doi: 10.1007/s00394-003-0397-3
– volume: 13
  start-page: 301
  issue: 3
  year: 2012
  end-page: 307
  ident: CR16
  article-title: Naringin attenuates enhanced cough, airway hyperresponsiveness and airway inflammation in a guinea pig model of chronic bronchitis induced by cigarette smoke
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2012.04.019
– ident: CR9
– volume: 36
  start-page: 212
  issue: 2
  year: 2004
  end-page: 225
  ident: CR22
  article-title: Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2003.09.022
– volume: 50
  start-page: 1725
  issue: 6
  year: 2002
  end-page: 1730
  ident: CR2
  article-title: Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro
  publication-title: J Agric Food Chem
  doi: 10.1021/jf0108056
– volume: 49
  start-page: 144
  issue: 3
  year: 1994
  end-page: 150
  ident: CR17
  article-title: Antiulcer effect of naringin on gastric lesions induced by ethanol in rats
  publication-title: Pharmacology
  doi: 10.1159/000139228
– volume: 7
  start-page: 407
  year: 2008
  end-page: 429
  ident: CR1
  article-title: Microbial metabolism of dietary phenolic compounds in the colon
  publication-title: Phytochem Rev
  doi: 10.1007/s11101-008-9095-3
– volume: 9
  start-page: 19
  issue: 1
  year: 1990
  end-page: 21
  ident: CR3
  article-title: Flavonoids as superoxide scavengers and antioxidants
  publication-title: Free Radic Biol Med
  doi: 10.1016/0891-5849(90)90045-K
– volume: 31
  start-page: 485
  issue: 3
  year: 2011
  end-page: 489
  ident: CR13
  article-title: Toxicokinetics of naringin, a putative antitussive, after 184-day repeated oral administration in rats
  publication-title: Environ Toxicol Pharmacol
  doi: 10.1016/j.etap.2011.01.006
– volume: 49
  start-page: 1640
  issue: 12
  year: 2001
  end-page: 1643
  ident: CR27
  article-title: The heterocyclic ring fission and dehydroxylation of catechins and related compounds by sp. strain SDG-2, a human intestinal bacterium
  publication-title: Chem Pharm Bull (Tokyo)
  doi: 10.1248/cpb.49.1640
– volume: 20
  start-page: 420
  issue: 5
  year: 1997
  ident: 193_CR28
  publication-title: Arch Pharm Res
  doi: 10.1007/BF02973933
– volume: 77
  start-page: 16
  issue: 1
  year: 2011
  ident: 193_CR7
  publication-title: Planta Med
  doi: 10.1055/s-0030-1250117
– volume: 181
  start-page: 428
  issue: 6
  year: 2004
  ident: 193_CR10
  publication-title: Arch Microbiol
  doi: 10.1007/s00203-004-0676-2
– volume: 49
  start-page: 144
  issue: 3
  year: 1994
  ident: 193_CR17
  publication-title: Pharmacology
  doi: 10.1159/000139228
– volume: 135
  start-page: 48
  issue: 1
  year: 2005
  ident: 193_CR26
  publication-title: J Nutr
  doi: 10.1093/jn/135.1.48
– volume: 13
  start-page: 301
  issue: 3
  year: 2012
  ident: 193_CR16
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2012.04.019
– volume: 21
  start-page: 17
  issue: 1
  year: 1998
  ident: 193_CR11
  publication-title: Arch Pharm Res
  doi: 10.1007/BF03216747
– volume: 12
  start-page: 140
  issue: 3
  year: 2006
  ident: 193_CR5
  publication-title: Anaerobe
  doi: 10.1016/j.anaerobe.2005.11.002
– volume: 136
  start-page: 1477
  issue: 6
  year: 2006
  ident: 193_CR23
  publication-title: J Nutr
  doi: 10.1093/jn/136.6.1477
– ident: 193_CR9
– volume: 130
  start-page: 1161
  issue: 4
  year: 1972
  ident: 193_CR8
  publication-title: Biochem J
  doi: 10.1042/bj1301161
– volume: 42
  start-page: 29
  issue: 1
  year: 2003
  ident: 193_CR18
  publication-title: Eur J Nutr
  doi: 10.1007/s00394-003-0397-3
– volume: 49
  start-page: 1640
  issue: 12
  year: 2001
  ident: 193_CR27
  publication-title: Chem Pharm Bull (Tokyo)
  doi: 10.1248/cpb.49.1640
– volume: 131
  start-page: 2648
  issue: 10
  year: 2001
  ident: 193_CR25
  publication-title: J Nutr
  doi: 10.1093/jn/131.10.2648
– volume: 11
  start-page: 1606
  issue: 10
  year: 2011
  ident: 193_CR14
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2011.05.022
– volume: 33
  start-page: 123
  issue: 3
  year: 2012
  ident: 193_CR15
  publication-title: Biopharm Drug Dispos
  doi: 10.1002/bdd.1775
– volume: 62
  start-page: 181
  issue: 4
  year: 2012
  ident: 193_CR29
  publication-title: Arzneimittelforschung
  doi: 10.1055/s-0031-1299746
– volume: 71
  start-page: 6077
  issue: 10
  year: 2005
  ident: 193_CR4
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.71.10.6077-6085.2005
– volume: 284
  start-page: 681
  issue: 3
  year: 2001
  ident: 193_CR12
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.2001.5001
– volume: 690
  start-page: 207
  issue: 1–3
  year: 2012
  ident: 193_CR20
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2012.06.040
– volume: 31
  start-page: 485
  issue: 3
  year: 2011
  ident: 193_CR13
  publication-title: Environ Toxicol Pharmacol
  doi: 10.1016/j.etap.2011.01.006
– volume: 15
  start-page: 894
  issue: 10
  year: 2012
  ident: 193_CR19
  publication-title: J Med Food
  doi: 10.1089/jmf.2012.2251
– volume: 7
  start-page: 407
  year: 2008
  ident: 193_CR1
  publication-title: Phytochem Rev
  doi: 10.1007/s11101-008-9095-3
– volume: 32
  start-page: 387
  issue: 4
  year: 2004
  ident: 193_CR21
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.32.4.387
– volume: 173
  start-page: 71
  issue: 1
  year: 2000
  ident: 193_CR24
  publication-title: Arch Microbiol
  doi: 10.1007/s002030050010
– volume: 9
  start-page: 19
  issue: 1
  year: 1990
  ident: 193_CR3
  publication-title: Free Radic Biol Med
  doi: 10.1016/0891-5849(90)90045-K
– volume: 36
  start-page: 212
  issue: 2
  year: 2004
  ident: 193_CR22
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2003.09.022
– volume: 50
  start-page: 1725
  issue: 6
  year: 2002
  ident: 193_CR2
  publication-title: J Agric Food Chem
  doi: 10.1021/jf0108056
– volume: 65
  start-page: 523
  issue: 4
  year: 2001
  ident: 193_CR6
  publication-title: Microbiol Mol Biol Rev
  doi: 10.1128/MMBR.65.4.523-569.2001
– reference: 22766066 - Eur J Pharmacol. 2012 Sep 5;690(1-3):207-13
– reference: 11729263 - Microbiol Mol Biol Rev. 2001 Dec;65(4):523-69, table of contents
– reference: 22985397 - J Med Food. 2012 Oct;15(10 ):894-900
– reference: 22374702 - Biopharm Drug Dispos. 2012 Apr;33(3):123-34
– reference: 11584085 - J Nutr. 2001 Oct;131(10):2648-52
– reference: 10648107 - Arch Microbiol. 2000 Jan;173(1):71-5
– reference: 11396955 - Biochem Biophys Res Commun. 2001 Jun 15;284(3):681-8
– reference: 21787720 - Environ Toxicol Pharmacol. 2011 May;31(3):485-9
– reference: 15127184 - Arch Microbiol. 2004 Jun;181(6):428-34
– reference: 22575871 - Int Immunopharmacol. 2012 Jul;13(3):301-7
– reference: 11767089 - Chem Pharm Bull (Tokyo). 2001 Dec;49(12):1640-3
– reference: 18982483 - Arch Pharm Res. 1997 Oct;20(5):420-4
– reference: 15039291 - Drug Metab Dispos. 2004 Apr;32(4):387-97
– reference: 2170243 - Free Radic Biol Med. 1990;9(1):19-21
– reference: 16204524 - Appl Environ Microbiol. 2005 Oct;71(10):6077-85
– reference: 16702307 - J Nutr. 2006 Jun;136(6):1477-82
– reference: 22270844 - Arzneimittelforschung. 2012 Apr;62(4):181-6
– reference: 9875509 - Arch Pharm Res. 1998 Feb;21(1):17-23
– reference: 16765860 - Anaerobe. 2006 Jun;12(3):140-7
– reference: 14744633 - Free Radic Biol Med. 2004 Jan 15;36(2):212-25
– reference: 7972328 - Pharmacology. 1994 Sep;49(3):144-50
– reference: 11879065 - J Agric Food Chem. 2002 Mar 13;50(6):1725-30
– reference: 12594539 - Eur J Nutr. 2003 Jan;42(1):29-42
– reference: 4656801 - Biochem J. 1972 Dec;130(4):1161-2
– reference: 20645246 - Planta Med. 2011 Jan;77(1):16-21
– reference: 21640201 - Int Immunopharmacol. 2011 Oct;11(10):1606-12
– reference: 15623831 - J Nutr. 2005 Jan;135(1):48-52
SSID ssj0000389556
Score 2.214663
Snippet Naringin, a major flavonoid in citrus fruits, has been proved to be a promising antitussive candidate. It undertakes complicated metabolism. In this study,...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 363
SubjectTerms Bacteria - metabolism
Biomedical and Life Sciences
Biomedicine
Feces - chemistry
Female
Flavanones - metabolism
Flavonoids - metabolism
Human Physiology
Humans
Intestines - metabolism
Intestines - microbiology
Male
Medical Biochemistry
Pharmaceutical Sciences/Technology
Pharmacology/Toxicology
Pharmacy
Phenylpropionates - metabolism
Short Communication
Title Human intestinal microbial metabolism of naringin
URI https://link.springer.com/article/10.1007/s13318-014-0193-x
https://www.ncbi.nlm.nih.gov/pubmed/24935725
https://www.proquest.com/docview/1708893873
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NS8MwFA-yXbyI386PUUF20BW6pGmS45DNoSA7bDBPJW0SGGyd2A7cf-9LP1ZkKnjrIU3Key_J79f38gtCd4CQBZVcuEqowPU1hnXQV74LJI4bwWBCFdUWr8Fo6j_P6Kw8x51W1e5VSjJfqevDbgTiD6ivrZoQxAXg2KSWukMQT3F_-2PFKsZRWuQogSExwPNVNvOnXr7vRzsgcydBmu87w0N0UAJGp194-Ajt6eQYdcaF4vSm60zqA1Rp1-k441qLenOCevlPeseKQsBcth0t57n0kn3SGUTAYp4unZVxEmnHnyenaDocTB5HbnlLghv73MtcLXxKDe4ZEcRaGcF5wLEhQARiYL6RjDxqqIhZEPckZwpLGSgcUCkjHZgYK3KGGskq0RfI4VxFQvqG6ZiD27AkDBOtwMkc-8ajLeRVtgrjUkLc3mSxCGvxY2veEMwbWvOGny10v33lvdDP-KvxbeWAEKLcpi5kolfrNOwxW45FOCMtdF54ZtsdEEhCGYave6hcFZYTMf19rMt_tb5C-4CUaFFcdo0a2cda3wAayaI2avaf3l4G7TwKvwCYftfS
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LSwMxEA5SD3oR39bnCtKDdqFNNpvkWMRStZYeWugtZDcJFNqtuC3Yf-9kHy1SFbztIZuEmUnyTWbmC0J3gJAFVVz4WujQDwyGfTDQgQ9OHLeCwYLKsy16YWcYvIzoqKjjTsts9zIkme3U62I3AvYHrq_LmhDEB-C4DViAuzyuIW6tLlYcYxyleYwSPCQGeL6MZv7Uy_fzaANkbgRIs3OnvY_2CsDotXINH6AtkxyiWj9nnF7WvcG6gCqtezWvv-aiXh6hZnZJ7zlSCFjLrqPpOKNecl9mDhYwGadTb2a9RLnxx8kxGrafBo8dv3glwY8D3pj7RgSUWty0IoyNtoLzkGNLwBGIwfONVNSgloqYhXFTcaaxUqHGIVUqMqGNsSYnqJLMEnOGPM51JFRgmYk5qA0rwjAxGpTMcWAbtIoapaxkXFCIu5csJnJNfuzEK0G80olXflbR_eqX95w_46_Gt6UCJFi5C12oxMwWqWwyl45FOCNVdJprZtUdOJCEMgyzeyhVJYuFmP4-1vm_Wt-gnc7grSu7z73XC7QLqInmiWaXqDL_WJgrQCbz6DqzxC8i-Nkx
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LSwMxEA6iIF7Et_W5gnjQLu4mm01yLGrxRenBQm8hu0mgULfibsH-eyf7aBEf4G0P2STMTJJvMjNfEDoHhCyo4sLXQsd-ZDDsg5GOfHDiuBUMFlSVbdGL7wfR45AO63dO8ybbvQlJVjUNjqUpK67ftL1eFL4RsEVwg10GhSA-gMgV2I1DZ9YD3Jlfsjj2OEqreCV4SwywfRPZ_KmXr2fTN8D5LVhankHdDbReg0evU2l7Ey2ZbAtd9Cv26Vnbe1kUU-Vt78LrL3ipZ9soLC_sPUcQAevadfQ6KmmY3JcpwBrGo_zVm1gvU278UbaDBt27l5t7v34xwU8jHhS-ERGlFodWxKnRVnAec2wJOAUpeMGJSgJqqUhZnIaKM42VijWOqVKJiW2KNdlFy9kkM_vI41wnQkWWmZSDCrEiDBOjQeEcRzagLRQ0spJpTSfuXrUYywURshOvBPFKJ1750UKX81_eKi6NvxqfNQqQYPEujKEyM5nmMmQuNYtwRlpor9LMvDtwJgllGGZ31ahK1osy_32sg3-1PkWr_duufH7oPR2iNQBQtMo5O0LLxfvUHANIKZKT0hA_AcsN3W0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+intestinal+microbial+metabolism+of+naringin&rft.jtitle=European+journal+of+drug+metabolism+and+pharmacokinetics&rft.au=Zou%2C+Wei&rft.au=Luo%2C+Yulong&rft.au=Liu%2C+Menghua&rft.au=Chen%2C+Si&rft.date=2015-09-01&rft.issn=0378-7966&rft.eissn=2107-0180&rft.volume=40&rft.issue=3&rft.spage=363&rft.epage=367&rft_id=info:doi/10.1007%2Fs13318-014-0193-x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s13318_014_0193_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0378-7966&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0378-7966&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0378-7966&client=summon